Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hospital Universitari Joan XXIII de Tarragona. | OTHER |
| Hospital Universitari Sant Joan de Reus | OTHER |
| University Rovira i Virgili | OTHER |
Not provided
Not provided
Not provided
Not provided
Animal models and studies on small samples of obese adults have shown that gut microbial diversity and certain types of bacteria could predict the efficacy of the dietetic treatment to improve body mass index (BMI) and the components of metabolic syndrome (MetS). Gut microbiota could distinguish the obese with metabolic syndrome patient than that metabolically healthy. Dietetic therapy could induce changes in the microbiota that could lead to improvement of BMI and the components of the MetS. The aim of MICROBEkids is to test whether the motivational intervention a motivational intervention (OBEMAT2.0) (PI15/00970) is more effective than the conventional intervention to increase the gut microbial diversity and, as a consequence, to improve BMI and MetS components. The role of gut microbiota (through modulation of the short chain fatty acids) will be analyzed as cardiovascular risk factor and as predictor of treatment success. These objectives will be achieved through a clustered clinical trial design with an intervention group that will receive a motivational therapy compared to a control group that will receive a conventional intervention, both during 12 months. The study sample are 319 children (n= 167 in the intervention group) that were enrolled in the clinical trial OBEMAT2.0 (PI15/00970), have had a comprehensive clinical assessment before the intervention (ages 8 to 14) and after 12 months (+3) of therapy (ages 9 to 15) and furthermore have participated in a biological samples collection for the investigation on childhood obesity (COLOBEPED, reference C.0004585).
The study will provide light to several hypothesis:
- The main hypothesis is that the dietetic intervention in obese children may improve the components of the metabolic syndrome by mediation (at least in part) of changes in the microbiota.
Other secondary hypothesis to be demonstrated are:
How these hypothesis will be demonstrated? A motivational structured intervention to reduce weight is applied (under randomized clustered design) to obese children, that are compared to an active intervention (not structured) provided by health care professionals, both groups during 12 months (+3).
A baseline and final assessment (before and after the intervention) are performed, in which the following information is collected:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Obemat2.0 Intervention Group | Experimental | Obese children (BMI >97th percentile of the Spanish curves from Hernández 1988) Ages: 8 to 13 at baseline (9 to 15y at the end of the intervention) |
|
| Control Group | Active Comparator | Obese children (BMI >97th percentile of the Spanish curves from Hernández 1988) Ages: 8 to 13 at baseline (9 to 15y at the end of the intervention) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Obemat2.0 therapy | Other | Lifestyle (diet & physical activity) structured recommendations through a motivational interview. Duration: 12(+3) months Description: 1 visit/month & 3 Workshops in primary care centers Providers: pediatricians and nurses trained to perform motivational interview The interviews are structured as follows: First, checking the accomplishment of objectives to motivate the participant. Second, a specific topic per visit is explained to the participant. Third, a task related to the topic (i.e. to plan a weekly menu for the family) is given to be brought back at the next visit. 4th. Objectives about diet, weight & physical activity are defined to be accomplished until the next visit. |
| Measure | Description | Time Frame |
|---|---|---|
| Fecal microbial diversity (diversity index like Gini-Simpson) | Effect of the intervention on increments of Fecal microbial diversity | 12 (+3) months |
| Measure | Description | Time Frame |
|---|---|---|
| Fecal Short Chain Fatty Acids: butyrate acid (μg) | Effect of the intervention and microbiota on increments Short Chain Fatty Acids | 12 (+3) months |
| Fecal Short Chain Fatty Acids: acetic acid (μg) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Veronica Luque | Institut d'Investigació Sanitària Pere Virgili | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of Medicine, C/ Sant Llorenç 21 | Reus | Tarragona | 43201 | Spain | ||
| Iispv- Hospital Sant Joan de Reus |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35777107 | Result | Alcazar M, Escribano J, Ferre N, Closa-Monasterolo R, Selma-Royo M, Feliu A, Castillejo G, Luque V; Obemat2.0 Study Group. Gut microbiota is associated with metabolic health in children with obesity. Clin Nutr. 2022 Aug;41(8):1680-1688. doi: 10.1016/j.clnu.2022.06.007. Epub 2022 Jun 15. | |
| 41711285 | Derived | Alcazar M, Luque V, Ferre N, Munoz-Hernando J, Gispert-Llaurado M, Closa-Monasterolo R, Feliu A, Castillejo G, Escribano J. Children's gut microbiota predicts the efficacy of obesity treatment. Gut Microbes. 2026 Dec 31;18(1):2631824. doi: 10.1080/19490976.2026.2631824. Epub 2026 Feb 19. |
| Label | URL |
|---|---|
| Preliminar (baseline) results | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003141 | Communicable Diseases |
| D063766 | Pediatric Obesity |
| ID | Term |
|---|---|
| D007239 | Infections |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Usual Clinical Practice | Other | Lifestyle (diet and physical activity) Duration: 12 (+3) months Description: 1visit/month to the primary care centers. Providers: pediatricians & nurses. Children assigned to the control group receive the usual treatment conducted in primary care centers based on the Clinical Practice Guidelines on the Prevention and Treatment of Child and Adolescent Obesity [Spanish Ministry of Science and Innovation], 2009). At visits, the family receive recommendations to carry out a balanced diet, to provide a moderate energy reduction from the previous intake. An increase in physical activity, both in terms of leisure activity, as sports is advised. |
|
|
Effect of the intervention and microbiota on increments Short Chain Fatty Acids
| 12 (+3) months |
| Fecal Short Chain Fatty Acids: propionic acid (μg) | Effect of the intervention and microbiota on increments Short Chain Fatty Acids | 12 (+3) months |
| Akkermansia Muciniphila (cfu) | Effect of the intervention on increments of Akkermansia Muciniphila in feces | 12 (+3) months |
| Reus |
| Tarragona |
| E43204 |
| Spain |
| Hospital de Tarragona Joan XXIII | Tarragona | 43005 | Spain |
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |